0001127602-20-023610.txt : 20200814 0001127602-20-023610.hdr.sgml : 20200814 20200814164056 ACCESSION NUMBER: 0001127602-20-023610 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200812 FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoge Stephen CENTRAL INDEX KEY: 0001760669 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 201106029 MAIL ADDRESS: STREET 1: C/O MODERNA, INC. STREET 2: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-08-12 0001682852 Moderna, Inc. MRNA 0001760669 Hoge Stephen C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 President Common Stock 2020-08-12 4 S 0 932 69.05 D 1965598 D Common Stock 2020-08-12 4 S 0 3138 69.92 D 1962460 D Common Stock 2020-08-12 4 S 0 400 70.77 D 1962060 D Common Stock 2020-08-12 4 S 0 230 72.01 D 1961830 D Common Stock 2020-08-12 4 S 0 200 73.18 D 1961630 D Common Stock 2020-08-12 4 S 0 100 74.06 D 1961530 D Common Stock 2020-08-13 4 M 0 10000 .99 A 1971530 D Common Stock 2020-08-13 4 S 0 10000 69.05 D 1961530 D Common Stock 2020-08-13 4 S 0 4300 67.80 D 1957230 D Common Stock 2020-08-13 4 S 0 700 68.49 D 1956530 D Common Stock 4116 I By Valhalla, LLC Stock Option (Right to Buy) .99 2020-08-13 4 M 0 10000 0 D 2023-08-19 Common Stock 10000 847431 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on June 1, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.55 to $69.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.56 to $70.46. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.57 to $71.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.64 to $72.33. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.90 to $73.45. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.29 to $68.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.33 to $68.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. This option is fully vested and exercisable. /s/ Lori Henderson, as Attorney-in-Fact 2020-08-14